期刊文献+

单用或联合使用阿德福韦酯引起尿β2-微球蛋白改变的研究 被引量:5

下载PDF
导出
摘要 目的了解阿德福韦酯(ADV)单药或联合用药治疗慢性乙型肝炎(CHB)患者对尿β2-微球蛋白(β2-MG)的影响,为评估肾小管功能提供依据,为临床用药提供参考。方法单用或联合使用ADV治疗的CHB患者234例,检测尿B2-MG,分析其与用药时间、治疗方案、年龄、性别等因素之间的关系。结果随着用药时间的延长,尿β2-MG异常比例和严重程度逐年增加,各时间段比较差异无统计学意义(P〉0.05)。ADV单用或联合拉米夫定(LAM)或恩替卡韦(ETV)使用时,引起尿β2-MG异常之间差异无统计学意义(P〉0.05),但是与替比夫定(LdT)联合使用时,引起尿B2-MG异常比例与其它治疗方案之间差异有统计学意义(P〈0.05)。尿p2-MG异常与年龄之间不存在相关性(OR=0.996,P〉0.05),但是与性剐、用药时间均有相关性(P〈0.05),各组治疗方案的疗程差异无统计学意义(P〉0.05)。结论ADV单药或联合LAM或ETV用药时可引起尿B2-MG异常,与LdT联合使用时,β2-MG异常发生的可能性变小。男性患者、用药时间较长者更容易出现尿B2-MG异常。 Objective To analyze the changes of urinary β 2- microglobulin.ofpatients with chronic hepatitis b who received adefovir dipivoxil alone or with other antivirals therapy and provide a basis for assessing renal tubular function, and then provide a reference for clinical practice. Methods Data of 234 patients with chronic hepatitis b who received adefovir dipivoxil alone or with other antivirals therapy in outpatient follow- up of liver disease of our hospital were collected. Their urinary β2-microglobulin and analyze the correlation between urinary β2- microglobulin and treatment time programs were detected, the patient' s age, gender and so on. Results With the extension of treatment time, the proportion of abnormal changes of urine β2- microglobulin increased. The difference was no statistically significant ( P〉0.05 ) . There was no significant difference about the changes in urine β2- mieroglobulin caused by adefovir dipivoxil alone or combination with lamivudine or entecavir ( P〉0.05 ) , but the difference was statistically when compared with adefovir combination with telbivudine ( P〈0.05 ) .There was also no correlation between age and the changes in urine β2- microglobulin ( OR=0.996, P〉0.05 ) , But it was associated with gender and course of treatment ( P〈0.05 ) . No statistical differences between groups of treatment ( P〉0.05 ) . Conclusion ADV alone or with lamivudine or entecavir cause gradual increase in the proportion of urine β2-microglobulin abnormal. Urinary β2 microglobulin abnormalities show a lower incidence when using adefovir combination with telbivudine. Male patients and longer time treatment are more prone to arise abnormal in urine β2- microglobulin.
出处 《浙江临床医学》 2016年第2期253-255,共3页 Zhejiang Clinical Medical Journal
关键词 阿德福韦酯 尿Β2-微球蛋白 慢性乙型病毒性肝炎 Adefovir dipivoxil Urinary β2- microglobulin Chronic Hepatitis B
  • 相关文献

参考文献8

  • 1贾继东,李兰娟.慢性乙型肝炎防治指南(2010年版)[J].中华肝脏病杂志,2011,19(1):13-24. 被引量:3212
  • 2N. Gara,X. Zhao,M. T. CoUins,et al.Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B.Alimentary pharmacology & therapeutics,2012,35 (11): 1317-1325. 被引量:1
  • 3H. Eguchi,M. TsurutaJ. Tani,et al.Hypophosphatemic osteomalacia due to drag-induced Fanconi's syndrome rognostic values of serum cystatin C and beta2 microglobulin, urinary beta2 microglobulin and N-acetyl-beta-D-glucosaminidase in early acute renal failure after liver transplantation associated with adefovir dipivoxil treatment for hepatitis B. Internal medicine (Tokyo, Japan),2014,53(3):233N237. 被引量:1
  • 4王伟铭.肾小管功能检查的临床意义[J].肾脏病与透析肾移植杂志,2007,16(5):451-452. 被引量:4
  • 5N. Tanji,K. Tanji,N. Kambham,et al.Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. Human pathology, 2001, 32(7):734-740. 被引量:1
  • 6罗金君.尿β2-MG在糖尿病肾病早期诊断中的价值[J].海南医学院学报,2005,11(1):40-41. 被引量:1
  • 7E. J. Gane,G. Deray,Y. F. Liaw,et al.Telbivudine improves renal function in patients with chronic hepatitis B. Gastroenterology,2014, 146(1):138-146. 被引量:1
  • 8K. H. Liang,Y. C. Chen,C. W. Hsu,et al.Decrease of serum Angiotensin converting enzyme levels upon telbivudine treatment for chronic hepatitis B yirus infection and negative correlations between the enzyme levels and estimated glumerular filtration rates. Hepatitis monthly, 2014, 14(1): e15074. 被引量:1

二级参考文献15

共引文献3214

同被引文献37

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部